Grossman Adam S
SEC CIK 1542517 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADMA | ADMA BIOLOGICS, INC. | Pres, CEO, Interim CFO, Dir | 2.13M | $435.7K | $20.90M | 65 | 2021-09-29 | 2026-03-16 |
Most active insiders at ADMA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Grossman Adam S | Pres, CEO, Dir | — | $1.74M |
| 2 | Grossman Jerrold B | Dir | $250.9K | — |
| 3 | ELMS STEVE | Dir | $217.4K | — |
| 4 | Kestenberg-Messina Kaitlin M. | COO, SVP, Compliance | — | $157.8K |
| 5 | Tade Brad L. | CFO, Treas | — | — |
| 6 | Salas Eduardo Rene | Dir | — | — |
| 7 | Kohler Terry | CFO, Treas | — | — |
| 8 | KWON YOUNG | Dir | — | — |
| 9 | FINGER ALISON CECILY | Dir | — | — |
| 10 | Guiheen Lawrence P. | Dir | — | — |
Transactions 65
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-03-17 | 2026-03-16 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | M - OptEx | $5.40 | +15.0K | 2.13M | +0.7% | +$81.0K |
| DMT | 2026-03-17 | 2026-03-16 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale+OE | $15.16 | -21.0K | 2.12M | -1.0% | -$318.4K |
| M | 2026-03-10 | 2026-03-06+ | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $15.39 | -86.0K | 2.15M | -4% | -$1.32M |
| 2026-03-02 | 2026-02-26 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $15.18 | -54.9K | 2.20M | -2% | -$832.7K | |
| 2026-02-23 | 2026-02-19 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $16.32 | -24.8K | 2.26M | -1% | -$404.6K | |
| DMT | 2026-02-17 | 2026-02-17 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale+OE | $16.08 | -21.0K | 2.29M | -0.9% | -$337.7K |
| DT | 2026-02-17 | 2026-02-17 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | M - OptEx | $5.40 | +15.0K | 2.31M | +0.7% | +$81.0K |
| D | 2026-02-11 | 2026-02-09 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | A - Grant | $0.00 | +282.5K | 2.29M | +14% | $0 |
| DMT | 2025-12-16 | 2025-12-15 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale+OE | $19.79 | -21.0K | 2.01M | -1% | -$415.6K |
| DT | 2025-12-16 | 2025-12-15 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | M - OptEx | $5.40 | +15.0K | 2.03M | +0.7% | +$81.0K |
| DMT | 2025-11-21 | 2025-11-19 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale+OE | $16.00 | -21.0K | 2.02M | -1% | -$336.0K |
| DT | 2025-11-21 | 2025-11-19 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | M - OptEx | $5.40 | +15.0K | 2.03M | +0.7% | +$81.0K |
| DMT | 2025-10-24 | 2025-10-24 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale+OE | $16.00 | -21.0K | 2.02M | -1% | -$336.0K |
| DT | 2025-10-24 | 2025-10-24 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | M - OptEx | $5.40 | +15.0K | 2.04M | +0.7% | +$81.0K |
| DT | 2025-09-16 | 2025-09-15 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | M - OptEx | $5.40 | +15.0K | 2.05M | +0.7% | +$81.0K |
| DMT | 2025-09-16 | 2025-09-15 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale+OE | $16.13 | -21.0K | 2.03M | -1% | -$338.7K |
| DT | 2025-08-15 | 2025-08-15 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | M - OptEx | $5.40 | +15.0K | 2.05M | +0.7% | +$81.0K |
| DMT | 2025-08-15 | 2025-08-15 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale+OE | $16.88 | -21.0K | 2.03M | -1% | -$354.5K |
| DMT | 2025-07-16 | 2025-07-15 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale+OE | $18.66 | -21.0K | 2.04M | -1% | -$391.9K |
| DT | 2025-07-16 | 2025-07-15 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | M - OptEx | $5.40 | +15.0K | 2.06M | +0.7% | +$81.0K |
| DT | 2025-06-18 | 2025-06-16 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | M - OptEx | $5.40 | +15.0K | 2.06M | +0.7% | +$81.0K |
| DMT | 2025-06-18 | 2025-06-16 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale+OE | $20.81 | -21.0K | 2.04M | -1% | -$437.0K |
| DT | 2025-05-16 | 2025-05-15 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | M - OptEx | $5.40 | +15.0K | 2.07M | +0.7% | +$81.0K |
| DMT | 2025-05-16 | 2025-05-15 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale+OE | $19.45 | -21.0K | 2.06M | -1% | -$408.4K |
| DMT | 2025-04-16 | 2025-04-15 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale+OE | $21.46 | -21.0K | 2.06M | -1% | -$450.7K |
| DT | 2025-04-16 | 2025-04-15 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | M - OptEx | $5.40 | +15.0K | 2.08M | +0.7% | +$81.0K |
| DT | 2025-03-21 | 2025-03-19 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | M - OptEx | $5.40 | +15.0K | 2.08M | +0.7% | +$81.0K |
| DMT | 2025-03-21 | 2025-03-19 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale+OE | $18.92 | -21.0K | 2.06M | -1% | -$397.3K |
| M | 2025-03-10 | 2025-03-06+ | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $16.95 | -86.0K | 2.07M | -4% | -$1.46M |
| M | 2025-02-27 | 2025-02-25+ | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $15.70 | -72.9K | 2.21M | -3% | -$1.14M |
| D | 2025-02-21 | 2025-02-19 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | A - Grant | $0.00 | +252.0K | 2.23M | +13% | $0 |
| 2025-01-03 | 2024-12-31 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $17.15 | -14.3K | 1.97M | -0.7% | -$246.0K | |
| 2024-11-22 | 2024-11-22 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale | $21.10 | -49.0K | 1.99M | -2% | -$1.03M | |
| 2024-10-02 | 2024-09-30 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $19.99 | -21.8K | 2.04M | -1% | -$434.8K | |
| DM | 2024-08-27 | 2024-08-26+ | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | M - OptEx | $4.64 | +626.2K | 2.20M | +40% | +$2.90M |
| DM | 2024-08-27 | 2024-08-26+ | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale+OE | $17.44 | -626.2K | 2.06M | -23% | -$10.92M |
| 2024-07-02 | 2024-06-30 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Interim CFO, Dir | F - Tax | $11.18 | -21.8K | 2.06M | -1% | -$243.2K | |
| 2024-06-14 | 2024-06-14 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Interim CFO, Dir | G - Gift | $0.00 | -10.0K | 2.18M | -0.5% | $0 | |
| 2024-06-14 | 2024-06-14 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Interim CFO, Dir | J - Other | $3.21 | -460.0K | 2.19M | -17% | -$1.48M | |
| 2024-06-14 | 2024-06-14 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Interim CFO, Dir | S - Sale | $10.72 | -100.0K | 2.08M | -5% | -$1.07M | |
| 2024-04-02 | 2024-03-31 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Interim CFO, Dir | F - Tax | $6.60 | -21.8K | 2.65M | -0.8% | -$143.6K | |
| M | 2024-03-08 | 2024-03-06+ | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $6.13 | -83.8K | 2.67M | -3% | -$513.8K |
| 2024-03-04 | 2024-02-29 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $5.36 | -9,588 | 2.76M | -0.3% | -$51.4K | |
| D | 2024-02-28 | 2024-02-26 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | A - Grant | $0.00 | +557.7K | 2.77M | +25% | $0 |
| 2024-02-27 | 2024-02-25 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $5.26 | -22.5K | 2.21M | -1% | -$118.1K | |
| 2024-01-05 | 2023-12-31 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $4.52 | -23.1K | 2.23M | -1% | -$104.2K | |
| 2023-10-03 | 2023-09-30 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $3.58 | -18.7K | 2.25M | -0.8% | -$67.0K | |
| 2023-08-18 | 2023-08-18 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale | $4.15 | -250.0K | 2.27M | -10% | -$1.04M | |
| DM | 2023-08-17 | 2023-08-15 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | M - OptEx | $3.11 | +2.10M | 3.29M | +177% | +$6.54M |
| DM | 2023-08-17 | 2023-08-15+ | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | S - Sale+OE | $4.54 | -510.5K | 4.11M | -11% | -$2.32M |
| D | 2023-08-17 | 2023-08-15 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $4.61 | -1.59M | 2.52M | -39% | -$7.33M |
| 2023-07-05 | 2023-06-30 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $3.69 | -20.1K | 2.52M | -0.8% | -$74.0K | |
| 2023-04-04 | 2023-03-31 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $3.31 | -17.9K | 2.54M | -0.7% | -$59.1K | |
| DM | 2023-03-08 | 2023-02-25+ | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $3.43 | -49.5K | 2.01M | -2% | -$169.9K |
| D | 2023-03-08 | 2023-03-06 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | A - Grant | $0.00 | +573.7K | 2.58M | +29% | $0 |
| 2023-01-06 | 2023-01-04 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $3.87 | -166.9K | 2.04M | -8% | -$645.8K | |
| 2022-12-09 | 2022-12-09 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | P - Purchase | $2.86 | +15.0K | 2.20M | +0.7% | +$42.9K | |
| I | 2022-12-09 | 2022-12-09 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | P - Purchase | $2.86 | +15.0K | 1.14M | +1% | +$42.8K |
| 2022-10-04 | 2022-09-30 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $2.43 | -101.3K | 2.19M | -4% | -$246.2K | |
| 2022-05-13 | 2022-05-11 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $1.43 | -70.0K | 2.29M | -3% | -$100.1K | |
| 2022-03-25 | 2022-03-23 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | F - Tax | $1.46 | -50.5K | 2.36M | -2% | -$73.8K | |
| D | 2022-03-09 | 2022-03-07 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | A - Grant | $0.00 | +300.0K | 2.41M | +14% | $0 |
| I | 2021-10-26 | 2021-10-25 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | P - Purchase | $1.00 | +250.0K | 1.13M | +28% | +$250.0K |
| 2021-10-26 | 2021-10-25 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | P - Purchase | $1.00 | +100.0K | 2.14M | +5% | +$100.0K | |
| M | 2021-10-01 | 2021-09-29 | ADMA | ADMA BIOLOGICS, INC. | Grossman Adam S | Pres, CEO, Dir | A - Grant | $0.00 | +1.65M | 2.04M | +426% | $0 |
Purchase Sale Sale after option exercise All abbreviations